BrightSpring Health Services BTSG
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
BrightSpring Health Services (BTSG) Business Model and Operations Summary
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Key Insights
BrightSpring Health Services (BTSG) Core Market Data and Business Metrics
Latest Closing Price
$17.94Market Cap
$3.12 BillionAverage Daily Trade Volume
1,546,031 SharesPrice-Earnings Ratio
-199.33Total Outstanding Shares
174.97 Million SharesCEO
Mr. Jon B. RousseauTotal Employees
600Dividend
No dividendIPO Date
January 26, 2024SIC Description
Services-home Health Care ServicesPrimary Exchange
NASDAQHeadquarters
805 N. Whittington Parkway, Louisville, KY, 40222
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $48.18 Million |
| Net Cash Flow From Financing Activities, Continuing | $164.65 Million |
| Net Cash Flow From Operating Activities, Continuing | $23.77 Million |
| Net Cash Flow From Financing Activities | $164.65 Million |
| Net Cash Flow From Investing Activities | $-140.24 Million |
| Net Cash Flow From Operating Activities | $23.77 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $-2.46 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Income/Loss From Continuing Operations After Tax | $-20.52 Million |
| Cost Of Revenue | $9.68 Billion |
| Depreciation and Amortization | $204.48 Million |
| Selling, General, and Administrative Expenses | $1.38 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-29.19 Million |
| Other Comprehensive Income/Loss | $-11.13 Million |
| Comprehensive Income/Loss | $-31.65 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-670,000 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $5.93 Billion |
| Wages | $139.42 Million |
| Equity | $1.65 Billion |
| Other Current Assets | $1.25 Billion |
| Long-term Debt | $2.61 Billion |
| Redeemable Noncontrolling Interest | $3.73 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||